Zobrazeno 1 - 6
of 6
pro vyhledávání: ''
Publikováno v:
Frontiers in Pharmacology, Vol 13 (2022)
Angong Niuhuang Pill (ANP) is a famous traditional Chinese patent medicine and is used for treating ischemic or hemorrhagic stroke for centuries. However, the mechanism of action of ANP in stroke treatment has rarely been reported. With increasing ev
Externí odkaz:
https://doaj.org/article/d14f419caf86468d8894008756dd4d81
Publikováno v:
Frontiers in Pharmacology, Vol 13 (2022)
Chemical liver injury is closely related to gut microbiota and its metabolites. In this study, we combined 16S rRNA gene sequencing, 1H NMR-based fecal metabolomics and GC-MS to evaluate the changes in gut microbiota, fecal metabolites and Short-chai
Externí odkaz:
https://doaj.org/article/651767fe8a0c475381b4470db40b0920
Publikováno v:
Frontiers in Pharmacology, Vol 12 (2021)
Accumulating evidences suggested an association between gut microbiome dysbiosis and impaired glycemic control. Ginsenoside Rb1 (Rb1) is a biologically active substance of ginseng, which serves anti-diabetic effects. However, its working mechanism es
Externí odkaz:
https://doaj.org/article/6a8edb6264dd41349f8eb9444e748381
Autor:
Jincai Dong, Wen Gu, Xingxin Yang, Linxi Zeng, Xi Wang, Jiankang Mu, Yanfang Wang, Fengjiao Li, Min Yang, Jie Yu
Publikováno v:
Frontiers in Pharmacology, Vol 12 (2021)
Objectives:Polygonatum kingianum is a medicinal herb used in various traditional Chinese medicine formulations. The polysaccharide fraction of P. kingianum can reduce insulin resistance and restore the gut microbiota in a rat model of aberrant lipid
Externí odkaz:
https://doaj.org/article/1744be7105c44dc5a7d0a41ffb6e0f96
Autor:
Huantian Cui, Yuting Li, Yuming Wang, Lulu Jin, Lu Yang, Li Wang, Jiabao Liao, Haoshuo Wang, Yanfei Peng, Zhaiyi Zhang, Hongwu Wang, Xiangguo Liu
Publikováno v:
Frontiers in Pharmacology, Vol 11 (2020)
The dysbiosis in gut microbiota could affect host metabolism and contribute to the development of nonalcoholic fatty liver disease (NAFLD). Da-Chai-Hu decoction (DCH) has demonstrated protective effects on NAFLD, however, the exact mechanisms remain
Externí odkaz:
https://doaj.org/article/a7ce89980a5a4fb8aa8c0fb61336b0fe
Autor:
Shuqing Gong, Tingting Ye, Meixia Wang, Mengying Wang, Yufei Li, Lina Ma, Yulian Yang, Yi Wang, Xiaoping Zhao, Li Liu, Min Yang, Huan Chen, Jing Qian
Publikováno v:
Frontiers in Pharmacology, Vol 11 (2020)
High-fat diet (HFD)-induced obesity is a risk factor for many metabolic disorders including cardiovascular diseases, diabetes, and fatty liver disease. Although there are accumulating evidences supporting the assumption that regulating gut microbiota
Externí odkaz:
https://doaj.org/article/e5b80ebfc1ba47258d4c1e74d07ead46